Literature DB >> 13335815

[Four years of experience with chlorpromazine in therapy of psychoses].

J DELAY, P DENIKER, R ROPERT.   

Abstract

Entities:  

Keywords:  CHLORPROMAZINE/therapeutic use; MENTAL DISORDERS/therapy; PSYCHOSES/therapy

Mesh：

Substances：

Year:  1956        PMID： 13335815

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0032-7867            Impact factor:   1.228


× No keyword cloud information.
  4 in total

1.  [Clinical experiences with a new piperazine derivative of phenothiazine in neuropsychiatry].

Authors:  H ENSS; K HARTMANN; H HIPPIUS; H E RICHTER
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1958

2.  Association of CYP2D6 polymorphisms and extrapyramidal symptoms in schizophrenia patients receiving risperidone: a retrospective study.

Authors:  Takahiro Ito; Kazuhiro Yamamoto; Fuminori Ohsawa; Ikuo Otsuka; Akitoyo Hishimoto; Ichiro Sora; Midori Hirai; Ikuko Yano
Journal:  J Pharm Health Care Sci       Date:  2018-11-19

3.  Influence of first- and second-generation antipsychotics on anthropometric parameters of male psychiatric patients.

Authors:  Maseqhala P Nkondo-Ndaba; Pierre M Joubert; Theona Ballyram; Charl Janse van Rensburg
Journal:  S Afr J Psychiatr       Date:  2022-02-17       Impact factor: 1.550

Review 4.  Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.

Authors:  Marco Solmi; Andrea Murru; Isabella Pacchiarotti; Juan Undurraga; Nicola Veronese; Michele Fornaro; Brendon Stubbs; Francesco Monaco; Eduard Vieta; Mary V Seeman; Christoph U Correll; André F Carvalho
Journal:  Ther Clin Risk Manag       Date:  2017-06-29       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.